Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2018
Source ID
10.1016/j.ygyno.2018.09.019

Entities

People

  • Analisa DiFeo
  • Anil Belur Nagaraj
  • Olga Kovalenko
  • Peronne Joseph
  • Quanqiu Wang
  • Rong Xu

Organizations

  • American Cancer Society
  • Clinical and Translational Science Collaborative of Northern Ohio
  • Mary Kay Foundation
  • National Cancer Institute
  • National Institutes of Health
  • United States Department of Defense